Updated on 11 October 2026
Pharma Innovation Accelerator
CEO/ Founder at MF BIOTECH
Berlin, Germany
About
The Pharma Innovation Accelerator is a collaborative workshop model for researchers, clinicians, project leaders and technology-transfer professionals working on early-stage therapeutic innovations, spin-offs or assets with out-licensing potential.
The format combines product-specific input with practical case studies, tools and group exercises. Participants explore how global development strategy, clinical and nonclinical development, CMC, regulatory interactions and approval planning can be integrated into a coherent pathway from scientific idea to clinical product. The content is tailored to the participating teams, their product classes and their development questions.
Looking for
- Joint development
- Knowledge transfer
- Technology transfer
Organisation
Similar opportunities
Expertise
Contract manufacturing for Biologics and CGT
Sami Ullah
Sr. Commercial Business Development Manager at ProBio Technology
Rijswijk, Germany
Expertise
Global Development Strategy & Regulatory Affairs
Michael Firgens
CEO/ Founder at MF BIOTECH
Berlin, Germany
Expertise
Translational Cell & Gene Therapy Development & Viral Vector Engineering
- DISEASE AREA | Cancer
- MEDICINE | Gene Therapy
- MEDICINE | Cell Therapy
- TECHNOLOGY | Bioengineering
- MEDICINE | Biomarker Discovery
- MEDICINE | Clinical Research, Trials
- TECHNOLOGY | (Single-cell) multi-omics
- TECHNOLOGY | Personalized disease models
- DISEASE AREA | Inflammation / Autoimmune Diseases
Filippos Theofilos Charitidis
Postdoctoral Researcher at Max Delbrück Center for Molecular Medicine
Berlin, Germany